BBT-301

N/A

Report date: 2024/10/11 13:54:34
NME

Base Information

Drug NameBBT-301
Drug Alias NameBBT-301CBM-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIon channels modulators
TargetsIon channels
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellionBioMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesBridge Biotherapeutics IncCellionBioMed Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A